Currier E, Illenye S, Ashikaga T, Lescault P, Bond J and Saulnier Sholler G.

Bortezomib and HDAC inhibitor PCI-24781 combination therapy for Neuroblastoma. April 2010 AACR Annual Meeting, Washington DC